Affluent market, medical tourism to steer best-in line drug delivery devices in India

Read more

Novartis seeks European approval for cell therapy Kymriah

Read more

GSK gets boost for early cancer hopes with breakthrough status

Read more

Biotech firms race to recruit good bugs in war on cancer

Read more

Merck’s drug gets US FDA approval

Read more

Sandoz says new clinical data support two biosimilars

Read more

Novartis posts eye drug data amid play for Eylea’s turf

Read more

J&J’s Stelara shows promise against lupus in study

Read more

‘We received an excellent reaction from the European market’

Read more

Risk-based monitoring: Gaining ground

Read more